Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow…

Embed Size (px)

DESCRIPTION

3 CML. Historical vs. Modern Perspective ParameterHistoricalModern CourseFatalIndolent PrognosisPoorExcellent 7-yr survival40%90% Frontline Rx Allogeneic SCT; IFN-  Imatinib Second line Rx? New Tyrosine Kinase Inhibitors; allo SCT